IP Roundup

Premium

Nanosys of Palo Alto, Calif., has received US Patent No. 7,910,064, "Nanowire-based sensor configurations." The patent claims nanowire-based molecular sensors and methods for detecting analytes in a microfluidic system. The methods include detecting changed electrical parameters associated with contact of a nanowire with the analyte in the system. According to the patent, the sensors are mounted in microchambers of the system in electrical contact with the detector, allowing electrical parameter changes induced in the nanowire by the analyte to be monitored.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.